Becton Dickinson Q1 FY25: where the revenue came from and where it went
The whole income statement of Becton Dickinson for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2024
- Reported
- Feb 6, 2025
Revenue$5.17B
+10% year over year
Gross profit$2.24B
43% margin
Operating profit$0.45B
9% margin
Net profit$0.30B
6% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 5.17 | 100% | +10% |
| Medical | 2.62 | 51% | +17% |
| Life sciences | 1.30 | 25% | +1% |
| Interventional | 1.26 | 24% | +6% |
| Cost of revenue | −2.93 | 57% | |
| Gross profit | 2.24 | 43% margin | +0pp |
| R&D | −0.34 | 7% | +0pp |
| SG&A | −1.32 | 25% | +0pp |
| Other | −0.12 | 2% | +0pp |
| Operating profit | 0.45 | 9% margin | −1pp |
| Interest & other costs | −0.15 | ||
| Net profit | 0.30 | 6% margin | +0pp |
76 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest